Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

PHO: Photocure to present at four investor conferences in November/December 2023

Photocure
Press Release - Oslo, Norway, November 20, 2023: Photocure ASA (OSE: PHO), The
Bladder Cancer Company, announces its participation in four investor conferences
focusing on the healthcare sector in Q4 2023:

The SEB Healthcare Seminar will take place in Stockholm, November 21-23, 2023.
David Moskowitz, Photocure's Vice President Investor Relations will present a
corporate overview on November 22 at 10:40am CET.

The 35[th] Annual Piper Sandler Healthcare Conference will be held in New York
City, November 28-30, 2023. Dan Schneider, Photocure's President and CEO will
present on November 28 at 9:50am ET. A webcast of the presentation will be
available at: Photocure ASA (PHO NO) - 1644046
(webcasts.com) (https://pgi.webcasts.com/starthere.jsp?ei=1644046&tp_key=04b1c8d
9
a7)

The 2023 Nordic American Healthcare Conference is scheduled to be held December
6-7 in New York City. Dan Schneider will present a corporate overview on
December 6 at 2:30pm ET.

The 14[th] Annual DNB Nordic Healthcare Conference will be held in Oslo on
December 14, 2023. Photocure's President and CEO Dan Schneider will present a
corporate overview at 3:35pm CET.

For further information, please contact:

Dan Schneider
President and CEO
Photocure ASA
Email: ds@photocure.com

Erik Dahl
CFO
Photocure ASA
Tel: +4745055000
Email: ed@photocure.com

David Moskowitz
Vice President, Investor Relations
Photocure ASA
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com

Media and IR enquiries:

Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.